Nature Communications (Sep 2021)

New-onset IgG autoantibodies in hospitalized patients with COVID-19

  • Sarah Esther Chang,
  • Allan Feng,
  • Wenzhao Meng,
  • Sokratis A. Apostolidis,
  • Elisabeth Mack,
  • Maja Artandi,
  • Linda Barman,
  • Kate Bennett,
  • Saborni Chakraborty,
  • Iris Chang,
  • Peggie Cheung,
  • Sharon Chinthrajah,
  • Shaurya Dhingra,
  • Evan Do,
  • Amanda Finck,
  • Andrew Gaano,
  • Reinhard Geßner,
  • Heather M. Giannini,
  • Joyce Gonzalez,
  • Sarah Greib,
  • Margrit Gündisch,
  • Alex Ren Hsu,
  • Alex Kuo,
  • Monali Manohar,
  • Rong Mao,
  • Indira Neeli,
  • Andreas Neubauer,
  • Oluwatosin Oniyide,
  • Abigail E. Powell,
  • Rajan Puri,
  • Harald Renz,
  • Jeffrey Schapiro,
  • Payton A. Weidenbacher,
  • Richard Wittman,
  • Neera Ahuja,
  • Ho-Ryun Chung,
  • Prasanna Jagannathan,
  • Judith A. James,
  • Peter S. Kim,
  • Nuala J. Meyer,
  • Kari C. Nadeau,
  • Marko Radic,
  • William H. Robinson,
  • Upinder Singh,
  • Taia T. Wang,
  • E. John Wherry,
  • Chrysanthi Skevaki,
  • Eline T. Luning Prak,
  • Paul J. Utz

DOI
https://doi.org/10.1038/s41467-021-25509-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Infection with SARS-CoV2 and the development of Coronavirus disease 2019 (COVID-19) has been linked to induction of autoimmunity and autoantibody production. Here the authors characterise the new-onset IgG autoantibody response in hospitalised patients with COVID-19 which they correlate to the magnitude of the SARS-CoV2 response.